...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript

Ug.

Just noticed that I had used CREDA iinstead of CRADA throughout.

Sorry about that.

Should be CRADA.

Not sure where my head was.

Share
New Message
Please login to post a reply